AmerisourceBergen Corporation (ABC): Price and Financial Metrics


AmerisourceBergen Corporation (ABC)

Today's Latest Price: $97.99 USD

0.19 (0.19%)

Updated Oct 20 6:30pm

Add ABC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

ABC Stock Summary

  • Amerisourcebergen Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.37% of US listed stocks.
  • With a price/sales ratio of 0.11, Amerisourcebergen Corp has a higher such ratio than only 3.25% of stocks in our set.
  • In terms of volatility of its share price, ABC is more volatile than only 2.19% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Amerisourcebergen Corp, a group of peers worth examining would be DXLG, SYY, MCK, MAT, and BGI.
  • Visit ABC's SEC page to see the company's official filings. To visit the company's web site, go to www.amerisourcebergen.com.

ABC Stock Price Chart Interactive Chart >

Price chart for ABC

ABC Price/Volume Stats

Current price $97.99 52-week high $106.45
Prev. close $97.80 52-week low $72.06
Day low $97.39 Volume 726,091
Day high $99.00 Avg. volume 1,358,037
50-day MA $97.55 Dividend yield 1.72%
200-day MA $93.67 Market Cap 20.00B

AmerisourceBergen Corporation (ABC) Company Bio


AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. The company was founded in 1985 and is based in Chesterbrook, Pennsylvania.

ABC Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$97.99$22.93 -77%

Below please find a table outlining a discounted cash flow forecast for ABC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Amerisourcebergen Corp ranked in the 18th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Amerisourcebergen Corp ended up being:

  • Amerisourcebergen Corp's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 23.8% of tickers in our DCF set.
  • ABC's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than merely 23.8% of tickers in our DCF set.
  • As a business, Amerisourcebergen Corp experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than only 0% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-77%
1%-77%
2%-77%
3%-76%
4%-76%
5%-76%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ABC, try DHR, ICUI, TFX, EHC, and MMSI.


ABC Latest News Stream


Event/Time News Detail
Loading, please wait...

ABC Latest Social Stream


Loading social stream, please wait...

View Full ABC Social Stream

Latest ABC News From Around the Web

Below are the latest news stories about Amerisourcebergen Corp that investors may wish to consider to help them evaluate ABC as an investment opportunity.

Good Neighbor Pharmacy Hosts First Virtual ThoughtSpot 2020 Conference & Trade Show

VALLEY FORGE, Pa.--(BUSINESS WIRE)--Today, AmerisourceBergen and Good Neighbor Pharmacy kicked off the first virtual ThoughtSpot, Good Neighbor Pharmacy’s annual conference and trade show, representing the organization’s continued commitment to ensuring pharmacists have the resources they need to be the pharmacy of choice in their communities, especially in this dynamic time. ThoughtSpot 2020 included a virtual general session and keynote address, more than 40 on-demand continuing education (CE

Business Wire | September 15, 2020

IntrinsiQ Specialty Solutions Launches UroChartEHR® Telehealth to Offer Urologists a HIPAA-Compliant Virtual Visit Tool

CARROLLTON, Texas--(BUSINESS WIRE)--IntrinsiQ Specialty Solutions, a part of AmerisourceBergen, today announced the launch of UroChartEHR Telehealth, a new HIPAA-compliant, virtual visit tool created in partnership with Backline by DrFirst. The solution allows urologists to quickly extend patient care beyond the traditional doctor’s office and connect with each other and with patients from any location at any time. With UroChartEHR Telehealth, urology patients now have the added convenience of

Business Wire | September 9, 2020

AmerisourceBergen: The Highest Quality Healthcare Company On Sale

Over the past few months, large portions of my capital have been allocated to investments in the Healthcare/Pharma sector. The undervaluation of the sector in comparison to the broader market has made the companies herein more and more interesting, with available upsides in double digits based even on fairly conservative...

Wolf Report on Seeking Alpha | September 4, 2020

Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update

This article is part of a series that provides an ongoing analysis of the changes made to Larry Robbins' 13F portfolio on a quarterly basis. It is based on Robbins' regulatory 13F Form filed on 08/14/2020. Please visit our Tracking Larry Robbins' Glenview Capital Management Portfolio article for an idea...

John Vincent on Seeking Alpha | September 4, 2020

AmerisourceBergen must face derivative suit over contaminate chemo drugs

Drug wholesaler AmerisourceBergen Corp and some of its executives and directors must face a shareholder lawsuit over its sale of unsterile chemotherapy drugs and payments of kickbacks to doctors, which have already resulted in $885 million in criminal and civil penalties, a Delaware judge has ruled.

Reuters | August 24, 2020

Read More 'ABC' Stories Here

ABC Price Returns

1-mo 1.20%
3-mo -5.22%
6-mo 13.32%
1-year 15.15%
3-year 24.36%
5-year 15.27%
YTD 16.82%
2019 16.48%
2018 -17.57%
2017 19.51%
2016 -23.32%
2015 16.39%

ABC Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ABC Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7543 seconds.